Genetics of Male Infertility: A Marker of Overall Health
男性不育的遗传学:整体健康的标志
基本信息
- 批准号:10613339
- 负责人:
- 金额:$ 162.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAdoptionAdultAgeBenefits and RisksBiologicalCRISPR/Cas technologyCardiovascular DiseasesCell MaintenanceCenter for Translational Science ActivitiesChildCitiesClinicCollaborationsCommunicationComplementCounselingCouplesDataData Coordinating CenterDevelopmentDiagnosisDiseaseEducationEducation and OutreachEpigenetic ProcessFaculty WorkshopFamilyFamily memberFemaleFertilityGenesGeneticGerm CellsHealthHigh School StudentHumanIndividualInfertilityInstitutionK-12 studentKnowledgeLeadLearning ModuleLife ExpectancyLinkMale InfertilityMalignant NeoplasmsMedicalMedical centerMetabolic syndromeMiddle School StudentMissionMutant Strains MiceMutationNew YorkOregonPatient RecruitmentsPatientsPhenotypePilot ProjectsPoliciesPregnancyProgram DescriptionQuestionnairesRecording of previous eventsReproductionReproductive HealthReproductive MedicineResearchResearch PersonnelScienceSertoli cell only syndromeSomatic CellSpecialized CenterStudentsSumTechnologyTestingTestisTimeTranslatingTranslationsUnited StatesUniversitiesVariantWashingtonWell in selfWorkassisted reproductioncareerclinical developmentclinical diagnosticscomorbiditycomorbidity Indexcostdata exchangediagnostic screeningeffectiveness evaluationepidemiologic dataepigenomefertility preservationgene therapygenetic variantgenome editinggenome sequencinghuman modelidiopathic infertilityimprovedindividualized medicinejunior high schoollaboratory experimentmalemanmedical schoolsmenmouse modelnovelpersonalized medicineprogramsprospectivereproductivesafety and feasibilitysertoli cellstem cell functionstem cellstargeted treatmentteacherunderserved communitywhole genome
项目摘要
Abstract: Overall
Azoospermia impacts 1% of men globally, which translates to 645,000 men between the ages of 20 and 50 in
the United States. It is estimated that genetic causes explain 50% of infertility. Epidemiological data suggest
that fertility status may be a marker of overall health, but the genetic underpinnings are just beginning to be
understood. Improved knowledge about the genetic basis of infertility and associated overall health
comorbidities will aid in the counseling of infertile couples; justify the development of diagnostic
screens; and may lead to patient-specific treatment options. In the current personalized medicine era with
reduced cost whole genome sequencing and facile genome editing technologies, it is feasible to discover
genetic underpinnings of infertility and overall health comorbidities and develop targeted therapies. Project I
will discover genetic variants in men with azoospermia to identify targets for development of clinical diagnostics
or therapy. Project I will use Charlson Comorbidity Index questionnaires to determine whether infertile patients
or their family members have histories of other overall health comorbidities. Project II will validate infertility-
associated genetic variants identified in Project I and characterize the fertility and overall health phenotypes.
Project II will also work collaborate with Project III to determine the impact of epigenetic perturbations on
spermatogonial stem cell function. Project III will develop Sertoli cell and germ cell gene therapies in mouse
models of azoospermia and will produce critical safety and feasibility data to inform the public dialogue on the
risks and benefits of gene therapy in and around the germline. The Pilot project will discover the epigenetic
landscape of germ cells and somatic cells from the testes of fertile versus infertile men. Core A will provide the
administrative oversight and facilitate communications and data exchange among projects and cores to ensure
that this P50 program achieves an impact that is greater than the sum of its parts. The Education and Outreach
Core will maximize the public impact of this P50 by developing hands-on teaching modules to educate middle
school and high school students as well as adults in underserved communities about reproductive medicine
and the genetics of infertility. Modules will be tested and validated in the Pitt Mobile Science lab before
deploying to teacher workshops in St. Louis, Pittsburgh, Ithaca and New York allowing teachers to implement
the modules in their classrooms. Male focused teaching modules will also be shared with P50 centers in
Oregon and at Northwestern to complement their existing female-focused hands-on modules.
摘要:总体而言
无精子症影响着全球1%的男性,这意味着全球有645,000名年龄在20至50岁之间的男性,
美国的据估计,遗传原因解释了50%的不孕症。流行病学数据表明
生育状况可能是整体健康的标志,但遗传基础才刚刚开始
明白提高对不孕症遗传基础和相关整体健康的认识
合并症将有助于不孕夫妇的咨询;证明诊断的发展是合理的
屏幕;并可能导致患者特定的治疗选择。在当前的个性化医疗时代,
降低成本的全基因组测序和简便的基因组编辑技术,
不孕症和整体健康共病的遗传基础,并开发有针对性的治疗方法。项目我
将发现无精子症男性的遗传变异,以确定临床诊断发展的目标
或者心理治疗项目I将使用Charlson Comorbidity Index问卷来确定不孕患者是否
或其家庭成员有其他总体健康共病史。项目二将验证不孕症-
项目I中确定的相关遗传变异,并表征生育力和总体健康表型。
项目II还将与项目III合作,确定表观遗传扰动对
精原干细胞功能项目III将开发小鼠支持细胞和生殖细胞基因疗法
无精子症的模型,并将产生关键的安全性和可行性数据,以告知公众对话,
基因治疗在生殖系内和生殖系周围的风险和益处。试点项目将发现表观遗传
生育男性与不育男性睾丸的生殖细胞和体细胞景观。核心A将提供
行政监督,促进项目和核心之间的通信和数据交换,以确保
这个P50计划的影响力大于其各个部分的总和。教育和推广
核心将通过开发实践教学模块来教育中等教育,
学校和高中学生以及服务不足社区的成年人了解生殖医学
和不育的遗传学。模块将在皮特移动的科学实验室进行测试和验证,
部署到圣路易斯、匹兹堡、伊萨卡和纽约的教师研讨会,让教师实施
在他们的教室里。以男性为重点的教学模块也将与P50中心共享,
俄勒冈州和西北大学,以补充他们现有的女性为重点的动手模块。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Human Spermatogenesis: Insights From the Clinical Care of Men With Infertility.
- DOI:10.3389/fendo.2022.889959
- 发表时间:2022
- 期刊:
- 影响因子:5.2
- 作者:
- 通讯作者:
Consensus label propagation with graph convolutional networks for single-cell RNA sequencing cell type annotation.
- DOI:10.1093/bioinformatics/btad360
- 发表时间:2023-06-01
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
High SARS-CoV-2 tropism and activation of immune cells in the testes of non-vaccinated deceased COVID-19 patients.
- DOI:10.1186/s12915-022-01497-8
- 发表时间:2023-02-16
- 期刊:
- 影响因子:5.4
- 作者:Costa, Guilherme M. J.;Lacerda, Samyra M. S. N.;Figueiredo, Andre F. A.;Wnuk, Natalia T.;Brener, Marcos R. G.;Andrade, Lidia M.;Campolina-Silva, Gabriel H.;Kauffmann-Zeh, Andrea;Pacifico, Lucila G. G.;Versiani, Alice F.;Antunes, Maisa M.;Souza, Fernanda R.;Cassali, Geovanni D.;Caldeira-Brant, Andre L.;Chiarini-Garcia, Helio;de Souza, Fernanda G.;Costa, Vivian V.;da Fonseca, Flavio G.;Nogueira, Mauricio L.;Campos, Guilherme R. F.;Kangussu, Lucas M.;Martins, Estefania M. N.;Antonio, Loudiana M.;Bittar, Cintia;Rahal, Paula;Aguiar, Renato S.;Mendes, Barbara P.;Procopio, Marcela S.;Furtado, Thiago P.;Guimaraes, Yuri L.;Menezes, Gustavo B.;Martinez-Marchal, Ana;Orwig, Kyle E.;Brieno-Enriquez, Miguel;Furtado, Marcelo H.
- 通讯作者:Furtado, Marcelo H.
Germ cell nests in adult ovaries and an unusually large ovarian reserve in the naked mole-rat.
- DOI:10.1530/rep-20-0304
- 发表时间:2021-01
- 期刊:
- 影响因子:0
- 作者:Place NJ;Prado AM;Faykoo-Martinez M;Brieño-Enriquez MA;Albertini DF;Holmes MM
- 通讯作者:Holmes MM
The Sertoli cell expressed gene secernin-1 (Scrn1) is dispensable for male fertility in the mouse.
- DOI:10.1002/dvdy.299
- 发表时间:2021-07
- 期刊:
- 影响因子:2.5
- 作者:Houston, Brendan J.;Nagirnaja, Liina;Merriner, D. Jo;O'Connor, Anne E.;Okuda, Hidenobu;Omurtag, Kenan;Smith, Craig;Aston, Kenneth I.;Conrad, Donald F.;O'Bryan, Moira K.
- 通讯作者:O'Bryan, Moira K.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kyle Edwin Orwig其他文献
Kyle Edwin Orwig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kyle Edwin Orwig', 18)}}的其他基金
Genetics of Male Infertility: A Marker of Overall Health
男性不育的遗传学:整体健康的标志
- 批准号:
10005443 - 财政年份:2019
- 资助金额:
$ 162.38万 - 项目类别:
Genetics of Male Infertility: A Marker of Overall Health
男性不育的遗传学:整体健康的标志
- 批准号:
10379346 - 财政年份:2019
- 资助金额:
$ 162.38万 - 项目类别:
Reproductive Development from Gonads to Fetuses
从性腺到胎儿的生殖发育
- 批准号:
10163223 - 财政年份:2017
- 资助金额:
$ 162.38万 - 项目类别:
Cellular Mechanisms of Chemotherapy-induced Male Infertility: Stem Cell or Niche?
化疗引起男性不育的细胞机制:干细胞还是利基?
- 批准号:
8636803 - 财政年份:2014
- 资助金额:
$ 162.38万 - 项目类别:
Cellular Mechanisms of Chemotherapy-induced Male Infertility: Stem Cell or Niche?
化疗引起的男性不育的细胞机制:干细胞还是利基?
- 批准号:
9085497 - 财政年份:2014
- 资助金额:
$ 162.38万 - 项目类别:
相似海外基金
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 162.38万 - 项目类别:
EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 162.38万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 162.38万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 162.38万 - 项目类别:
Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 162.38万 - 项目类别:
Standard Grant